首页> 外国专利> MULTIMERIC FUSION PROTEIN VACCINE AND IMMUNOTHERAPEUTIC

MULTIMERIC FUSION PROTEIN VACCINE AND IMMUNOTHERAPEUTIC

机译:多元融合蛋白疫苗和免疫治疗

摘要

The present disclosure provides fusion proteins that incorporate unique mechanisms for multimerizing antigens to enhance their immunogenicity. The fusion proteins comprise at least two antigens, or other vaccine related proteins, separated by a linker sequence and an oligomerization domain. When expressed, the fusion protein forms a muKimeric protein complex, This approach can be used to muHimeri?.e a single antigen/protein or to create multimers comprising two or more different antigens/proteins. Also provided are nucleic acids encoding the fusion proteins. Yet another aspect is directed to methods of inducing or suppressing an immune response in a subject by administering to the subject a vaccine composition comprising a fusion protein or nucleic acid encoding the fusion protein, optionally without using an adjuvant.
机译:本公开提供了融合蛋白,其融合了用于使抗原多聚以增强其免疫原性的独特机制。融合蛋白包含由接头序列和寡聚化结构域隔开的至少两种抗原或其他疫苗相关蛋白。当表达时,融合蛋白形成多聚体蛋白复合物。该方法可用于突变单个抗原/蛋白或产生包含两种或更多种不同抗原/蛋白的多聚体。还提供了编码融合蛋白的核酸。另一个方面涉及通过向受试者施用包含融合蛋白或编码融合蛋白的核酸,任选地不使用佐剂的疫苗组合物,在受试者中诱导或抑制免疫应答的方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号